Evidence map›Paper›PMID 35656978›Full record

ArticleJournal of the American Heart Association2022

Hydrophilic Versus Lipophilic Statin Treatments in Patients With Renal Impairment After Acute Myocardial Infarction.

Min Hye Kang, Weon Kim, Jin Sug Kim, Kyung Hwan Jeong, Myung Ho Jeong, Jin-Yong Hwang, Seung Ho Hur, Hyeon Seok Hwang

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Antitumoral and cardioprotective roles of statins: underlying types, mechanisms, current evidence, and emerging perspectives.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Min Hye KangDivision of Nephrology Department of Internal Medicine Kyung Hee University Seoul Republic of Korea.
Weon KimDivision of Cardiology Department of Internal Medicine Kyung Hee University Seoul Republic of Korea.
Jin Sug KimDivision of Nephrology Department of Internal Medicine Kyung Hee University Seoul Republic of Korea.
Kyung Hwan JeongDivision of Nephrology Department of Internal Medicine Kyung Hee University Seoul Republic of Korea.
Myung Ho JeongDepartment of Internal Medicine and Heart Center Chonnam National University Hospital Gwangju Republic of Korea.ORCID 0000-0001-7319-8562
Jin-Yong HwangDepartment of Internal Medicine Gyeongsang National University Hospital Jinju Republic of Korea.
Seung Ho HurDivision of Cardiology Keimyung University Medical Center Taegu Republic of Korea.
Hyeon Seok HwangDivision of Nephrology Department of Internal Medicine Kyung Hee University Seoul Republic of Korea.ORCID 0000-0002-6356-4933
Kyung Hee University · KRChonnam National University Hospital · KRGyeongsang National University Hospital · KRKeimyung University Dongsan Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Hydrophilic and lipophilic statins have similar efficacies in treating coronary artery disease. However, specific factors relevant to renal impairment and different arterial pathogeneses could modify the clinical effects of statin lipophilicity, and create differences in protective effects between statin types in patients with renal impairment. Methods and Results A total of 2062 patients with acute myocardial infarction with an estimated glomerular filtration rate <60 mL/min per 1.73 m

Indexed as

Coronary Artery DiseaseHydroxymethylglutaryl-CoA Reductase InhibitorsMyocardial InfarctionRenal InsufficiencyHumansProportional Hazards ModelsRegistriesTreatment OutcomeHydroxymethylglutaryl-CoA Reductase Inhibitorsacute myocardial infarctionhydrophilic statinmajor adverse cardiac and cerebrovascular eventsrenal impairmentstatin lipophilicity

Identifiers

PMID35656978
PMCPMC9238700
OpenAlexW4281646823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.